31 December 2024 in International Immunopharmacology
Secreted phosphoprotein 1 (SPP1) shows carcinogenic potential in multiple cancers, yet its role in nasopharyngeal carcinoma (NPC) remains elusive. Leveraging transcriptomic data sourced from an NPC cohort at Fujian Cancer Hospital, alongside datasets from the Gene Expression Omnibus cohort and a single-cell RNA sequencing dataset, this investigation explored the role of SPP1 in tumor progression and the tumor microenvironment of NPC. A co-culture system involving tumor cells and macrophages was established to elucidate the relationship between SPP1 and tumor-associated macrophages in NPC. Subsequently, we established an SPP1-driven M2 macrophage signature using a machine-learning-based framework to predict patient prognosis. The results of our analysis indicated that SPP1 is associated with an elevated risk of disease progression and poor prognosis in NPC. Single-cell analysis demonstrated that SPP1 is a pivotal gene in the polarization of M2 macrophages within the tumor microenvironment. In vitro experiments demonstrated that NPC-derived SPP1 has the potential to activate the CD44/JAK2/STAT3 signaling pathway, promoting macrophage recruitment and polarization of the M2 subtype. Furthermore, we established a comprehensive SPP1-related M2 macrophage signature that can predict the prognosis and immune characteristics of patients with NPC. Our findings offer new insights into the role of SPP1 in the tumor microenvironment of NPC, and provide a novel SPP1-driven M2 macrophage signature with the potential to serve as a valuable tool for prognosis prediction and personalized therapy in NPC.
31 October 2025 in Clinical and Experimental Obstetrics & Gynecology
Background: Endometriosis (EMS), which affects >10% of women, is characterized by painful symptoms, such as dysmenorrhea. Meanwhile, the gut microbiota is linked to EMS; however, the relationship between the gut microbiota and EMS-related pain remains unclear. Methods: This study conducted 16S rRNA sequencing on fecal samples from 20 patients with EMS and dysmenorrhea, 13 patients with EMS but not dysmenorrhea, and 12 healthy controls. Results: Carbohydrate antigen 125 (CA125) levels were significantly higher in patients with EMS and dysmenorrhea. No significant differences in α- and β-diversity values were observed among the three groups (p > 0.05). However, Proteobacteria and Subdoligranulum showed increased abundance trends in patients with EMS and dysmenorrhea. Acinetobacter and Colidextribacter were less abundant in patients with EMS and dysmenorrhea than in those without dysmenorrhea (p < 0.05). Faecalicoccus pleomorphus and its genus also showed consistent depletion. At the genus level, a correlation analysis of the differential microbes revealed that UCG_005 and UCG_002 were central nodes in the correlation network (p < 0.05). Functional prediction indicated significant enrichment in cofactor and vitamin metabolism pathways in the EMS group with dysmenorrhea (p < 0.05). Several differential microbes, such as Faecalicoccus, Colidextribacter, and Acinetobacter, were negatively correlated with pain severity. Receiver operating characteristic curve analysis identified 10 microbial species with moderate diagnostic potential (area under the curve >0.7) for discriminating patients with EMS and dysmenorrhea, notably Ligilactobacillus. Conclusions: These results highlight distinct microbial alterations and functional pathways associated with EMS-related pain, suggesting potential diagnostic biomarkers for this condition.
28 October 2022 in Andrologia
1 June 2023 in Journal of Clinical Oncology